Vetoquinol SA (LON:0O1O)

Market Cap	788.76M
Revenue (ttm)	445.90M
Net Income (ttm)	48.53M
Shares Out	n/a
EPS (ttm)	4.11
PE Ratio	16.25
Forward PE	14.80
Dividend	0.75 (0.98%)
Ex-Dividend Date	Jun 4, 2025

Volume	1
Average Volume	28
Open	76.00
Previous Close	75.01
Day's Range	76.00 - 76.20
52-Week Range	64.50 - 102.20
Beta	0.78
RSI	61.76
Earnings Date	Sep 11, 2025

About Vetoquinol

Vetoquinol SA, a veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products in Europe, the Americas, and the Asia Pacific region. It provides products in the areas of mobility, pain, and inflammation; dermatology, hygiene, and care; anti-parasite; udder health; infectious diseases; reproduction; behavior management; internal medicine; and cardiology-nephrology for cattle, pigs, dogs, and cats. The company was founded in 1933 and is headquartered in Lure, France. Vetoquinol SA is a subsidiary of S...

• Industry: Medical - Pharmaceuticals
• Sector: Healthcare
• Founded: 1933
• Employees: 2,501
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0O1O

Financial Performance

In 2024, Vetoquinol's revenue was 539.20 million, an increase of 1.88% compared to the previous year's 529.27 million. Earnings were 58.69 million, an increase of 5.62%.

Financial numbers in EUR